Physician profile

Eli Thompson

Urology · Los Angeles, CA

NPI 1952852386

$4,435.56

in general payments reported to CMS, 2019-2025

45 companies · $401 in 2025

The $401 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,123.73

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $362.49 2021-2024 Myrbetriq, Xtandi
Abbvie INC. $358.37 2022-2025 Botox, Lupron Depot
Boston Scientific Corporation $351.87 2019-2024 Rezum Generator, Greenlight Xps
Dendreon Pharmaceuticals LLC $328.34 2021-2025 Provenge
Sumitomo Pharma America, INC. $261.90 2023-2025 Orgovyx, Gemtesa
Merck Sharp & Dohme LLC $221.19 2022-2025 Keytruda, Lynparza, Welireg
Pfizer INC. $162.10 2020-2024
Myriad Genetic Laboratories, INC. $158.85 2020-2023 Prolaris, Myrisk
Amgen INC. $146.83 2019-2022
Tolmar, INC. $144.97 2023-2025 Eligard, Jatenzo
Bayer Healthcare Pharmaceuticals INC. $143.83 2023-2025
Urogen Pharma, INC. $143.44 2021-2025 Jelmyto
Astrazeneca Pharmaceuticals LP $126.04 2023-2024 Lynparza
Accord Healthcare, INC. $117.40 2023-2024
Janssen Biotech, INC. $102.58 2023-2025 Erleada
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Myovant Sciences INC. $89.33 2021-2022
180 Medical, INC. $84.24 2022-2023 Cure Catheter
Convatec INC. $80.02 2024-2025
Teleflex LLC $76.63 2021-2023 Urolift
Laborie Medical Technologies Corp. $73.25 2023-2024 Optilume Bph Drug Coated Balloon Catheter
Verity Pharmaceuticals INC. $66.11 2024 Trelstar, Tlando
Progenics Pharmaceuticals, INC. $65.59 2023-2025 Pylarify
Coloplast Corp $64.80 2021-2025 Self-Cath
Ferring Pharmaceuticals INC. $62.88 2024-2025 Adstiladrin
Telix Pharmaceuticals $61.41 2023-2025 Illuccix
Olympus America INC. $59.33 2021-2025 Itind System
Travere Therapeutics, INC. $52.13 2021-2022
Endo Pharmaceuticals INC. $44.80 2020-2023 Xiaflex, Aveed
Procept Biorobotics Corporation $42.18 2021-2023 Aquabeam Robotic System
Antares Pharma, INC. $41.22 2021-2022
Smith+Nephew, INC. $37.35 2024 Stravix Pl
Angiodynamics, INC. $34.11 2021
Sun Pharmaceutical Industries INC. $29.58 2022
Endo USA, INC. $26.67 2024 Xiaflex, Aveed
Foundation Medicine, INC. $24.38 2020
Immunitybio, INC. $24.05 2024
Alexion Pharmaceuticals, INC. $23.99 2019
Hollister Incorporated $20.67 2023 Vapro
Axonics, INC. $19.60 2023 Axonics, Bulkamid
Sagent Pharmaceuticals $18.94 2019
Genzyme Corporation $17.81 2022
Gilead Sciences, INC. $17.40 2021
Novartis Pharmaceuticals Corporation $16.11 2022
Kowa Pharmaceuticals America, INC. $15.82 2023 Seglentis
Cook Medical LLC $14.96 2024 Cook

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eli Thompson

$4,435.56

in general payments reported 2019-2025

Years
2019-2025
Top company
Astellas Pharma US INC
Context
The $401 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/2779845/eli-thompson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.